nivolumab
bms
['lung', 'checkmate816', 'check,mate,816']
 is first author of #checkmate816, a clinical trial presented at #esmo22 that examined data on the quality of life of patients with #nonsmallcelllungcancer 
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre